DISCOUNT ZERTIFIKAT - TEVA PHARMACEUTICAL INDUSTRIES Share Price

Certificat

DE000VM0RLA9

Delayed Deutsche Boerse AG 09:38:11 23/05/2024 BST
9.9 EUR -1.49% Intraday chart for DISCOUNT ZERTIFIKAT - TEVA PHARMACEUTICAL INDUSTRIES
Current month-0.79%
1 month+0.10%
Date Price Change
23/05/24 9.9 -1.49%
22/05/24 10.05 +0.20%
21/05/24 10.03 0.00%
20/05/24 10.03 +0.10%
17/05/24 10.02 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 09:38 am

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IssuerLogo Issuer Vontobel Vontobel
WKN VM0RLA
ISINDE000VM0RLA9
Date issued 09/08/2023
Cap 11 $
Last trading day 21/06/2024
Maturity 21/06/2024 (30 Days)
Parity 1 : 1
Emission price 7.87
Emission volume N/A
Payment day 28/06/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- $
Break even 0.000000 €
Highest since issue 10.13
Lowest since issue 7.37
Spread 0.25
Spread %2.46%
Distance Cap 5.88 $
Distance Cap %+34.83%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.88 USD
Average target price
17.34 USD
Spread / Average Target
+2.70%
Consensus